孕期带状疱疹与新生儿结局及神经发育障碍的全国性回顾性队列研究
多变量logistic回归及稳定逆概率治疗加权敏感性分析均显示,孕期带状疱疹与不良新生儿结局及2岁内神经发育障碍诊断无显著关联,孕20周前后诊断亦无显著关联。
要点
- 孕期带状疱疹与早产、低出生体重、低Apgar评分、先天缺陷无显著关联。
- 孕期带状疱疹与子代2岁内神经发育障碍诊断无显著关联。
- 孕20周前或后诊断带状疱疹均未显示与不良结局显著相关。
核心结论
- 孕期带状疱疹,包括孕20周前发生,与不良新生儿结局及2岁内神经发育障碍风险增加无关联。
研究设计与样本
- 全国性回顾性队列研究,分析台湾全民健康保险研究数据库2017至2020年数据。
主要发现
- 调整母亲年龄、社会经济剥夺及妊娠状态后,孕期带状疱疹与不良新生儿结局无显著关联。
- 孕期带状疱疹与子代2岁内神经发育障碍诊断无显著关联。
- 稳定逆概率治疗加权敏感性分析结果与主分析一致。
- 孕20周前或后诊断带状疱疹均未显示与不良新生儿结局或神经发育障碍显著相关。
临床怎么用
- 临床可据此向孕妇说明孕期带状疱疹极不可能影响新生儿健康或早期神经发育。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the association between maternal herpes zoster (HZ) during pregnancy, either before or after 20 weeks of gestation, and adverse neonatal outcomes, as well as neurodevelopmental disorders in offspring. STUDY DESIGN: This nationwide, retrospective cohort study analyzed data from the National Health Insurance Research Database in Taiwan between 2017 and 2020. Among 630 456 eligible singleton pregnancies, 2922 (0.46%) children were born to women diagnosed with HZ during pregnancy. The primary outcomes were adverse neonatal outcomes, including preterm delivery, low birth weight, low Apgar scores, and congenital defects. The secondary outcome was the diagnosis of a neurodevelopmental disorder within the first 2 years of life. Multivariable logistic regression models were used to evaluate the association between maternal HZ and adverse outcomes, with stabilized inverse probability of treatment weighting employed as a sensitivity analysis to confirm robustness. RESULTS: After adjusting for maternal age, socioeconomic deprivation, and gestational status using multivariable regression models, no significant associations were found between maternal HZ during pregnancy and adverse neonatal outcomes or neurodevelopmental disorders. Sensitivity analyses with stabilized inverse probability of treatment weighting yielded similar results. Furthermore, maternal HZ diagnosed before or after 20 weeks of gestation was not significantly associated with an adverse neonatal outcome or neurodevelopmental disorder. CONCLUSIONS: Maternal HZ during pregnancy, even before 20 weeks of gestation, was not associated with increased odds of adverse neonatal outcomes or neurodevelopmental disorders within the first 2 years of life. These findings reassure clinicians and pregnant women that an episode of HZ during pregnancy is highly unlikely to affect neonatal health or early neurodevelopment.
引用
- Chen YC, Tan PH, Liang FW, et al. Neonatal Outcomes and Neurodevelopmental Disorders Following Maternal Herpes Zoster During Pregnancy: A Nationwide Retrospective Cohort Study. J Pediatr. 2025. PMID: 40449830. doi:10.1016/j.jpeds.2025.114675
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。